Related Experiment Video

Updated: May 26, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate

Defeng Xu1, Tzu-Hua Lin, Shaoshun Li

  • 1School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.

Cancer Letters
|December 14, 2011
PubMed

Insights

Cryptotanshinone (CTS), a natural compound, effectively inhibits prostate cancer (PCa) cell growth by blocking androgen receptor (AR) activity. This discovery offers new therapeutic strategies for PCa treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products

Background:

  • Androgen receptor (AR) is a key target in prostate cancer (PCa) therapy.
  • Current anti-androgen therapies face limitations due to short-term effectiveness.

Purpose of the Study:

  • To investigate the efficacy of cryptotanshinone (CTS), a natural product, as a novel therapeutic agent for PCa.
  • To elucidate the mechanism by which CTS inhibits AR-mediated PCa growth.

Main Methods:

  • In vitro studies using AR-positive and AR-negative PCa cell lines (LNCaP, CWR22rv1, PC-3).
  • Assessment of CTS effects on AR transactivation, DHT-mediated gene expression (PSA, TMPRSS2, TMEPA1), and cell proliferation.
  • In vivo studies using a xenograft animal model.
  • Analysis of AR dimerization and AR-coregulator complex formation.

Main Results:

  • CTS (0.5 microM) significantly suppressed AR-positive PCa cell growth, with minimal impact on AR-negative cells and non-malignant prostate cells.
  • CTS effectively inhibited DHT-induced AR transactivation and expression of AR target genes in both androgen-responsive and castration-resistant PCa cells.
  • CTS selectively inhibited AR without affecting other nuclear receptors (ERα, GR, PR).
  • Mechanistic studies revealed CTS blocks AR dimerization and AR-coregulator complex formation.
  • CTS demonstrated efficacy in inhibiting tumor growth and AR target gene expression in a xenograft model.

Conclusions:

  • Cryptotanshinone (CTS) acts as a potent AR inhibitor, offering a promising therapeutic strategy for prostate cancer.
  • CTS selectively targets AR, inhibiting cancer cell proliferation and gene expression through novel mechanisms.
  • CTS's efficacy in preclinical models suggests its potential for developing new PCa treatments.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...